Detecting Colorectal Neoplasia Using Fecal Protease Substrates
Author Information
Author(s): Roza C. M. Opperman, Sofie Bosch, Kamran Nazmi, Floris J. Bikker, Henk S. Brand, Connie R. Jimenez, Tim G. J. de Meij, Evelien Dekker, Nanne K. H. de Boer, Wendy E. Kaman
Primary Institution: Amsterdam UMC, Vrije Universiteit Amsterdam
Hypothesis
This study aims to identify colorectal neoplasia-associated proteases and their substrates as a potential noninvasive screening test.
Conclusion
The study successfully developed colorectal neoplasia-specific fluorogenic substrates, particularly highlighting the ED substrate as a potential biomarker for detecting advanced adenomas and colorectal cancer.
Supporting Evidence
- Seven out of 18 substrates showed significantly decreased proteolytic degradation in feces from patients with colorectal neoplasia compared to controls.
- The ED substrate showed significantly decreased degradation in both advanced adenoma and colorectal cancer patients.
- Statistical analyses indicated significant differences in substrate degradation among the study groups.
Takeaway
Researchers created special tests to find signs of colon cancer in poop, which could help catch the disease early without needing a painful procedure.
Methodology
Eighteen fluorogenic substrates were tested on fecal samples from patients with colorectal cancer, advanced adenomas, nonadvanced adenomas, and controls to measure proteolytic degradation.
Limitations
The study had a small sample size and did not include the bacterial proteome for protease identification.
Participant Demographics
Participants included 12 with colorectal cancer, 9 with advanced adenomas, 10 with nonadvanced adenomas, and 14 controls, with no significant differences in age, gender, or other demographics.
Statistical Information
P-Value
p = 0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website